Beijing Huawei Pharmaceutical Co., Ltd. is a core subsidiary of Huawei Health Management Group, formerly under the Service Bureau of the National Health Commission (formerly the Ministry of Health) of the People's Republic of China. This unique identity endows Huawei Pharmaceutical with unique advantages and insights under the guidance of national medical and health policies.
Huawei Pharmaceutical has always resonated with the development pulse of the national medical and health care industry, and is an active responder to policies and a practitioner of the national health dream. Especially in the field of children's medical and health care, it has deeply cultivated and demonstrated a strong sense of social responsibility and mission.
Capital Empowerment & Commercialization
- Capital Empowerment: Joint capital investment
- Commercialization: Through in-license, CSO and other models, achieving complementary advantages and resources with innovative pharma companies, efficiently facilitating the commercial launch of new drugs.
Address: 28th Floor, Nanyin Building, No. 2 East Third Ring North Road, Chaoyang District, Beijing
Phone: 010-61006202
Personnel recruitment consultation: li-ll@moh-hw.com
Investment and BD cooperation: BD@moh-hw.com
Medical sales consultation: zhang-b@moh-hw.com
Huawei Health Management Group. All Rights Reserved (C) 2021
Powered by PharmNet.com.cn Toocle NetSun Copyright Notice 京ICP备2026038759
Online Drug and Medical Device Information Service Filing: Non-commercial -(京) Online Drug and Device Information Record No. (2026) 00146